ARCHIVES

Professional Societies: ASCO opposes FDA On Stem Cell Transplant Regs

This article is from The Cancer Letter archive.

Vol. 23 No. 19 | May 16, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997